跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
NUPRAFEN TABLET 250 MG
Approved
THERAPEUTIC
NUPRAFEN TABLET 250 MG
BEXIMCO PHARMACEUTICALS LTD (BANGLADESH)
🇸🇬 Health Sciences Authority
Approval Date
Feb 18, 1998
Approval ID
3274c4847a491c29
Company
BEXIMCO PHARMACEUTICALS LTD (BANGLADESH)
Type
Therapeutic
Approval Details
Approval Id
3274c4847a491c29
Drug Name
NUPRAFEN TABLET 250 MG
Product Name
NUPRAFEN TABLET 250 MG
Approval Number
SIN09646P
Approval Date
1998-02-18
Registrant
PHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence Holder
PHARMATECH MEDICAL ENTERPRISE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
M01AE02
Atc Item Name
naproxen
Pharma Manufacturer Name
PHARMATECH MEDICAL ENTERPRISE PTE. LTD.
Company Detail Path
/organization/pharmatech-medical-enterprise-pte-ltd
Active Ingredients
NAPROXEN
250 mg
NAPROXEN
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 18, 1998
Approval ID
3274c4847a491c29
Type
Therapeutic
Back to HSA Approvals
NUPRAFEN TABLET 250 MG - HSA Drug Approval Details